[Skip to Content]
[Skip to Content Landing]
May 4, 1994

Immunoaugmentative Therapy

JAMA. 1994;271(17):1319. doi:10.1001/jama.1994.03510410031021

To the Editor.  —I must comment on the last paragraph of Dr Green's polemic against immunoaugmentative therapy (IAT),1 which contains the statement, "While this paper was being reviewed for publication, an IAT proponent newsletter called The Cancer Chronicles published the news that Lawrence Burton died of a heart attack in March 1993. The editor of this newsletter, Ralph Moss, PhD, stated that Burton's clinic would remain open...."I wonder to what sort of publication review Green could be referring, since neither he nor The Journal contacted me to ascertain if The Cancer Chronicles is, in fact, an "IAT proponent" newsletter.It decidedly is not. Before the brief notice of Burton's death in March,2 the last article we published on the topic of IAT was a critique of the Office of Technology Assessment's ill-fated attempts to evaluate that treatment, which appeared in the winter 1989/1990 issue.3 That article